Global AI in Diagnostics Market to Reach USD4,829 Million Mark by 2030

• Overview
• Table of Content
• Research Methodology
• Download Free Sample

The Global AI in Diagnostics Market size was valued at around USD1,621 million in 2024 and is projected to reach USD4,829 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 19.95% during the forecast period, i.e., 2025-30, cites MarkNtel Advisors in the recent research report. The rise in the market is due to an increase in the demand for medical image scanning solutions, a rise in the digital infrastructure, the digitalization of hospitals, increasing 5G internet penetration, growing investments in AI generative technology models, government support, shortage of skilled health professionals, and others.

The demand for artificial intelligence and machine learning services has increased, especially in medical imaging. This is due to the frequent diagnosis of numerous diseases and illnesses, need for real-time monitoring, which enhances the imaging procedure of diagnostic devices such as MRI, CT, PET, X-ray, and ultrasound scans. Medical Imaging techniques such as U-Net, GAN, etc., solely rely on AI for the training of medical equipment. Thus, to train machine learning models, AI is integrated into the system to access and generate synthetic medical data for training.

Moreover, the support of the government through vision plans such as Digital India & IndiaAI Mission, AI Playbook, AI Opportunities Action Plan of the UK government, etc., for the digitalization of the sectors and development of the AI technologies, has increased lately. Under these programs, the governments of the US, EU, India, Singapore, etc. are investing in the development of the digital infrastructure, thus supporting the market. Thus, the increasing investments in healthcare, digital infrastructure, etc., and the rapid research and development in technology, fuel the market growth across the globe, further states the research report, “Global AI in Diagnostics Market Analysis, 2025.”

Global AI in Diagnostics Market Segmentation Analysis

Radiology Segment Holds the Largest Market Share

Based on the application, the market is further bifurcated into cardiology, oncology, pathology, radiology, chest & lung, neurology, and others. Radiology holds the majority of the market share of around 34%. This is due to the rising prevalence of diseases, advancements in technology, shortage of skilled radiologists, government support, digitalization of the healthcare sector, increasing need for imaging solutions, etc.

Moreover, the increasing cases of cancer, neurological disorders, accidental fractures, etc., have led to frequent radiological scans. The increased workload on the radiologist raises the probability of errors; thus, to minimize errors and reduce the workload with enhanced speed and accuracy, AI is integrated into the equipment of radiological diagnosis. Additionally, the support of the government through stringent standard regulations like the Medical Device Regulation of the EU and others led to the acceptance of technological advancements such as AI in the radiology department of hospitals, clinical laboratories, etc. Several key market players, such as Aidoc, GE Healthcare, and others, are investing and developing AI-powered X-ray, MRI, and ultrasound scanning devices, hence increasing the market share of radiology in the global market of AI diagnostics.

North America Spearheads the Global AI in Diagnostics Industry

North America dominates the AI in Diagnostics Market globally with a market share of around 39%. It is due to the strong presence of market players, rising cases of cardiac diseases, expanding digital infrastructure, increasing penetration of technology, advancements in AI technology & its integration in the healthcare sector, prevalence of technical solution providers, the growing government support, etc.

North America has well-established internet and digital connectivity, with 95% of the US anticipated to be connected with high-speed 5G internet services by the end of 2025, supporting the AI industry. The technological solution providers like Enlitic, Butterfly Network, Health Catalyst, and others are offering diagnostic solutions and services powered by AI. Thus, increasing its utility and consumption in medical image scanning, like X-ray, ultrasound, MRI, and other scans, in compliance with standard regulations such as FDA clearance imposed by the US authorities.

Thus, the streamlined and smooth operation of the healthcare sector, requiring regular and precise diagnosis for the treatment of the illness, and increasing investments in the AI-powered healthcare devices, promote the growth of the market in North America. 

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including Siemens Healthineers, Nanox Imaging Ltd., Riverain Technologies, Vuno Inc., Aidoc, Neural Analytics, Imagen Technologies, Digital Diagnostics Inc., GE Healthcare, AliveCor Inc., Enlitic, InformAI, Nvidia Corporation, Advanced Micro Devices Inc., Koninklijke Philips N.V., and others, are looking forward to strengthening their market positions.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
2. What are the trends influencing the current scenario of the market?
3. What key factors would propel and impede the industry across the globe?
4. How has the industry been evolving in terms of geography & solution adoption?
5. How has the competition been shaping up across various regions?
6. How have buying behavior, customer inclination, and expectations from solution providers been evolving during 2020-30?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?